Drug Profile
Minocycline sustained release - Beijing CoSci Med Tech
Latest Information Update: 12 Sep 2023
Price :
$50
*
At a glance
- Originator Beijing CoSci Med-Tech
- Class Amides; Anti-inflammatories; Antiacnes; Antibacterials; Dimethylamines; Eye disorder therapies; Neuroprotectants; Skin disorder therapies; Small molecules; Tetracyclines
- Mechanism of Action Glial cell inhibitors; Protein 30S ribosomal subunit inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Acne
Most Recent Events
- 12 Sep 2023 Discontinued - Preclinical for Acne in China (PO)
- 28 Aug 2020 No recent reports of development identified for preclinical development in Acne in China (PO, Controlled release)
- 27 Jul 2016 Chemical structure info added